COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,046 Articles (22,627 medRxiv, 8,419 bioRxiv)

Most recent first Previous |  Page 2346: Articles 23451-23460  | Next

COVID-19 in rheumatic diseases: A random cross-sectional telephonic survey
Kumar, U., Goswami, R. P., Bhadu, D., Kanjilal, M., Nagar, S., Vij, P., Mittal, D., Meena, L., Roy, D.
10.1101/2020.08.09.20170985 — Posted: 2020-08-13
Acute Lung injury evolution in Covid-19
Doglioni, C., Ravaglia, C., Rossi, G., Dubini, A., Pedica, F., Piciucchi, S., Vizzuso, A., Pecciarini, L., Stella, F., Maitan, S., Agnoletti, V., Gamberini, E., Russo, E., Puglisi, S., Arcadu, A., Donati, L., Di Cesare, S., Grosso, C., Poletti, G., Sambri, V., Fabbri, E., Pizzolo, G., Ugel, S., Bronte, V., Wells, A. U., Chilosi, M., Poletti, V.
10.1101/2020.08.09.20170910 — Posted: 2020-08-13
Protocol for a Rapid Scoping Review of Evidence of Outdoor Transmission of COVID-19
Weed, M., Foad, A.
10.1101/2020.08.07.20170373 — Posted: 2020-08-13
Coronacept - a potent immunoadhesin against SARS-CoV-2
Cohen-Dvashi, H., Weinstein, J., Katz, M., Eilon, M., Mor, Y., Shimon, A., Strobelt, R., Shemesh, M., Fleishman, S. J., Diskin, R.
10.1101/2020.08.12.247940 — Posted: 2020-08-12
Effect of Convalescent Plasma on Mortality among Hospitalized Patients with COVID-19: Initial Three-Month Experience
Joyner, M. J., Senefeld, J. W., Klassen, S. A., Mills, J. R., Johnson, P. W., Theel, E. S., Wiggins, C. C., Bruno, K. A., Klompas, A. M., Lesser, E. R., Kunze, K. L., Sexton, M. A., Diaz Soto, J. C., Baker, S. E., Shepherd, J. R. A., van Helmond, N., van Buskirk, C. M., Winters, J. L., Stubbs, J. R., Rea, R. F., Hodge, D. O., Herasevich, V., Whelan, E. R., Clayburn, A. J., Larson, K. F., Ripoll, J. G., Andersen, K. J., Buras, M. R., Vogt, M. N. P., Dennis, J. J., Regimbal, R. J., Bauer, P. R., Blair, J. E., Paneth, N. S., Fairweather, D., Wright, R. S., Carter, R. E., Casadevall, A.
10.1101/2020.08.12.20169359 — Posted: 2020-08-12 Discussion: Onsite | Offsite
Suppression of MDA5-mediated antiviral immune responses by NSP8 of SARS-CoV-2
Yang, Z., Zhang, X., Wang, F., Wang, P., Li, X., Kuang, E.
10.1101/2020.08.12.247767 — Posted: 2020-08-12
TRIM28 regulates SARS-CoV-2 cell entry by targeting ACE2
Wang, Y., Fan, Y., Huang, Y., Du, T., Liu, Z., Huang, D., Wang, Y., Wang, N., Zhang, P.
10.1101/2020.08.12.247825 — Posted: 2020-08-12
Membrane Nanoparticles Derived from ACE2-rich Cells Block SARS-CoV-2 Infection
Wang, C., Wang, S., Chen, Y., Zhao, J., Han, S., Zhao, G., Kang, J., Liu, Y., Wang, L., Wang, X., Xu, Y., Wang, S., Huang, Y., Wang, J., Zhao, J.
10.1101/2020.08.12.247338 — Posted: 2020-08-12
Efficacy of Targeting SARS-CoV-2 by CAR-NK Cells
Ma, M. T., Badeti, S., Geng, K., Liu, D.
10.1101/2020.08.11.247320 — Posted: 2020-08-12 Discussion: Onsite
Elicitation of potent neutralizing antibody responses by designed protein nanoparticle vaccines for SARS-CoV-2
Walls, A. C., Fiala, B., Schaefer, A., Wrenn, S., Pham, M. N., Murphy, M., Tse, L. V., Shehata, L., O'Connor, M. A., Chen, C., Navarro, M. J., Miranda, M. C., Pettie, D., Ravichandran, R., Kraft, J. C., Ogohara, C., Palser, A., Chalk, S., Lee, E.-C., Kepl, E., Chow, C. M., Sydeman, C., Hodge, E. A., Brown, B., Fuller, J. T., Dinnon, K., Gralinski, L., Leist, S. R., Gully, K. L., Lewis, T. B., Guttman, M., Chu, H. Y., Lee, K. K., Fuller, D. H., Baric, R. S., Kellam, P., Carter, L., Pepper, M., Sheahan, T. P., Veesler, D., King, N. P.
10.1101/2020.08.11.247395 — Posted: 2020-08-12 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).